Patrick Haffey is a seasoned executive with extensive experience in business development and strategic partnerships within the pharmaceutical and biotechnology sectors. Currently serving as Principal at Laney Rock Consulting since May 2024, Patrick advises corporate boards and executives on capital formation and commercialization strategies. Additionally, Patrick holds a position as an Advisory Board Member at Axio BioPharma, contributing to business strategy and capital formation. Prior to these roles, Patrick founded Selkirk Pharma in March 2018 and served as Chairman & CEO, addressing pharmaceutical manufacturing capacity issues in the US. Patrick's background also includes a role as Senior Manager of Global Business Development at Samsung BioLogics, where opportunities in biologic drug manufacturing were secured, and as Program Manager at Unicep, managing client accounts and business development. Patrick possesses dual MBA degrees from UCLA Anderson School of Management and the National University of Singapore, obtained in December 2018.
This person is not in the org chart
This person is not in any teams
This person is not in any offices